Exodus Point Capital Management, LP Caribou Biosciences, Inc. Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$4.82 - $8.26 $764,509 - $1.31 Million
158,612 New
158,612 $815,000
Q2 2023

Aug 10, 2023
BUY
$4.04 - $5.47 $158,974 - $215,244
39,350 New
39,350 $167,000
Q3 2022

Nov 10, 2022
SELL
$5.34 - $12.79 $290,196 - $695,059
-54,344 Closed
0 $0
Q2 2022

Aug 19, 2022
BUY
$5.1 - $9.74 $277,154 - $529,310
54,344 New
54,344 $295,000

Others Institutions Holding CRBU

# of Institutions
135
Shares Held
52.6M
Call Options Held
148K
Put Options Held
70.7K
View Full List

About Caribou Biosciences, Inc.

CRBU Quotes by TradingView
  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $133M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email